Blackstone Life Sciences’ $250 Million Investment in Anthos Therapeutics

Goodwin advised Anthos Therapeutics Inc. on the deal Blackstone Life Sciences and Novartis launched Anthos Therapeutics Inc., a new biopharmaceutical company focused on advancing next generation…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now